2-(1-adamantyl)pyrroline | 180258-71-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯啉
• 英文名称: 2-(1-adamantyl)pyrroline
• 英文别名: 5-(1-adamantyl)-3,4-dihydro-2H-pyrrole
• CAS: 180258-71-3
• 化学式: C₁₄H₂₁N
• mdl: MFCD24038863
• 分子量: 203.327
• InChiKey: UJTBQGPWLGJKKB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.928
• 拓扑面积：
  12.4
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-(1-adamantyl)pyrroline 在 sodium tetrahydroborate 、 溶剂黄146 作用下， 以 甲醇 为溶剂， 反应 4.0h， 以83%的产率得到2-(1-金刚烷基)吡咯烷盐酸盐
  参考文献：
  名称：

  Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. 2

  摘要：

  The synthesis of some new aminoadamantane derivatives is described. The new compounds were evaluated against a wide range of viruses [influenza A H1N1, influenza A H2N2, influenza A H3N2, influenza B, parainfluenza 3, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), thymidine kinase-deficient (TK-) HSV-1, vaccinia, vesicular stomatitis, polio 1, Coxsackie B4, Sindbis, Semliki forest, Reo 1, varicella-zoster virus (VZV), TK- VZV, human cytomegalo-virus (HCMV),,and human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2)]. Some of them proved markedly active against the influenza A H2N2 (compounds 4a,b, 5a, 6a, and 7a), H3N2 (compounds 5a, 6a, and 7a), and H1N1 (compounds 4b,c and 6d). Since compounds 5a, 6a, and 7a, amantadine, and rimantadine showed the same comparative pattern of potency against influenza strains H2N2, H3N2, and B, it may postulated that they act according to a similar mechanism, with regard to their ''amine'' effect, on the M2 ion channel of influenza A (H1N1, H2N2, or H3N2). In general, no significant activity was noted with any of the new compounds against any of the other viruses tested, making their activity against influenza virus more specific and striking. Borderline activity was noted with some of the compounds (4b,c, 5a-c, and 8a) against HIV-1.

  DOI：

  10.1021/jm950891z
• 作为产物：
  描述：

  1-(金刚烷-1-羰基)吡咯烷-2-酮 在 calcium oxide 作用下， 以34.5%的产率得到2-(1-adamantyl)pyrroline
  参考文献：
  名称：

  Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. 2

  摘要：

  The synthesis of some new aminoadamantane derivatives is described. The new compounds were evaluated against a wide range of viruses [influenza A H1N1, influenza A H2N2, influenza A H3N2, influenza B, parainfluenza 3, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), thymidine kinase-deficient (TK-) HSV-1, vaccinia, vesicular stomatitis, polio 1, Coxsackie B4, Sindbis, Semliki forest, Reo 1, varicella-zoster virus (VZV), TK- VZV, human cytomegalo-virus (HCMV),,and human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2)]. Some of them proved markedly active against the influenza A H2N2 (compounds 4a,b, 5a, 6a, and 7a), H3N2 (compounds 5a, 6a, and 7a), and H1N1 (compounds 4b,c and 6d). Since compounds 5a, 6a, and 7a, amantadine, and rimantadine showed the same comparative pattern of potency against influenza strains H2N2, H3N2, and B, it may postulated that they act according to a similar mechanism, with regard to their ''amine'' effect, on the M2 ion channel of influenza A (H1N1, H2N2, or H3N2). In general, no significant activity was noted with any of the new compounds against any of the other viruses tested, making their activity against influenza virus more specific and striking. Borderline activity was noted with some of the compounds (4b,c, 5a-c, and 8a) against HIV-1.

  DOI：

  10.1021/jm950891z

文献信息

• Synthesis of Tetrazole-Derived Organocatalysts via Azido-Ugi Reaction with Cyclic Ketimines
  作者：Olga I. Shmatova、Valentine G. Nenajdenko

  DOI：10.1021/jo401428q

  日期：2013.9.20

  A new route to tetrazole-derived cyclic amines based on the TMSN3-modified Ugi reaction with 2-substituted cyclic imines was elaborated. The reaction allows the direct preparation of five-, six-, and seven-membered cyclic amines substituted with a tetrazole ring, which are important types of organocatalysts. The scope and limitations of this method are discussed. In the case of the Ugi reaction with

  基于TMSN 3的四唑衍生环胺的新途径阐述了用2-取代的环状亚胺进行的修饰的Ugi反应。该反应允许直接制备被四唑环取代的五元，六元和七元环胺，这是重要的有机催化剂类型。讨论了该方法的范围和局限性。在Ugi与苄基异氰化物反应的情况下，N-取代的四唑可以在催化氢化条件下容易地脱苄基，以定量收率形成NH-四唑。证明了四唑衍生的环胺的两种对映体都可以通过酒石酸拆分而制备，从而引发了一种简单的手性衍生物路线。在胺化反应中，将获得的手性四唑之一有效地用作有机催化剂。
• Six-Component Azido-Ugi Reaction: from Cyclic Ketimines to Bis-Tetrazole-Derived 5-7-Membered Amines
  作者：Irina V. Kutovaya、Danil P. Zarezin、Olga I. Shmatova、Valentine G. Nenajdenko

  DOI：10.1002/ejoc.201900244

  日期：2019.4.24

  The six‐component azido‐Ugi reaction with 2‐substituted 5–7‐membered imines leads to mono‐ or bis‐tetrazole derivatives depending on the starting imines. The reaction is very general regarding isocyanide structure and enables preparation of 1,5‐disubstituted bis‐tetrazole derivatives connected with 5–7‐membered cyclic amine fragments. Subsequent catalytic debenzylation provides the corresponding 1H‐tetrazoles

  与2个取代的5-7元亚胺形成的六组分叠氮基-Ugi反应取决于起始的亚胺，生成单或双四唑衍生物。关于异氰酸酯的结构，该反应非常笼统，可制备与5-7元环胺片段连接的1,5-二取代双-四唑衍生物。随后的催化脱苄基作用提供了相应的1H-四唑。
• Transformation of cyclic ketimines to oxaziridines and nitrones
  作者：Natalia G. Voznesenskaia、Olga I. Shmatova、Valentine G. Nenajdenko

  DOI：10.1016/j.mencom.2017.01.008

  日期：2017.1

  Treatment of 5-, 6- and 7-membered cyclic ketimines bearing alkyl or aryl group with m-chloroperbenzoic acid proceeds as C=N epoxidation and affords bicyclic oxaziridines in good yields, whose subsequent rearrangement gives nitrones.

  用间氯过苯甲酸处理带有烷基或芳基的5-，6-和7-元环状酮亚胺，以C = N环氧化的方式进行，并以良好的收率得到双环恶唑烷，其随后的重排产生了硝酮。
• The reaction of cyclic imines with the Ruppert–Prakash reagent. Facile approach to α-trifluoromethylated nornicotine, anabazine, and homoanabazine
  作者：Nikolay E. Shevchenko、Katja Vlasov、Valentine G. Nenajdenko、Gerd-Volker Röschenthaler

  DOI：10.1016/j.tet.2010.11.032

  日期：2011.1

  We have demonstrated that the Ruppert-Prakash reagent is able to react with a number of cyclic imines under acidic condition to afford the corresponding alpha-trifluoromethyl derivatives of nitrogen heterocycles. 5-7-Membered cyclic imines bearing various alkyl, aryl or heterocyclic group were successfully involved in this transformation. Novel trifluoromethylated analogues of nicotine, anabasine, and homoanabasine alkaloids were synthesized. (C) 2010 Elsevier Ltd. All rights reserved.
• Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. 2
  作者：Nicolas Kolocouris、Antonios Kolocouris、George B. Foscolos、George Fytas、Johan Neyts、Elisabeth Padalko、Jan Balzarini、Robert Snoeck、Graciela Andrei、Erik De Clercq

  DOI：10.1021/jm950891z

  日期：1996.1.1

  The synthesis of some new aminoadamantane derivatives is described. The new compounds were evaluated against a wide range of viruses [influenza A H1N1, influenza A H2N2, influenza A H3N2, influenza B, parainfluenza 3, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), thymidine kinase-deficient (TK-) HSV-1, vaccinia, vesicular stomatitis, polio 1, Coxsackie B4, Sindbis, Semliki forest, Reo 1, varicella-zoster virus (VZV), TK- VZV, human cytomegalo-virus (HCMV),,and human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2)]. Some of them proved markedly active against the influenza A H2N2 (compounds 4a,b, 5a, 6a, and 7a), H3N2 (compounds 5a, 6a, and 7a), and H1N1 (compounds 4b,c and 6d). Since compounds 5a, 6a, and 7a, amantadine, and rimantadine showed the same comparative pattern of potency against influenza strains H2N2, H3N2, and B, it may postulated that they act according to a similar mechanism, with regard to their ''amine'' effect, on the M2 ion channel of influenza A (H1N1, H2N2, or H3N2). In general, no significant activity was noted with any of the new compounds against any of the other viruses tested, making their activity against influenza virus more specific and striking. Borderline activity was noted with some of the compounds (4b,c, 5a-c, and 8a) against HIV-1.